NLS Pharmaceutics News

6-K/A: Report of foreign private issuer [Rules 13a-16 and 15d-16] (Amendment)

Dec 20 05:24

425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Dec 19 21:34

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 19 21:34

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 18 05:34

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 12 00:40

425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Dec 12 00:40

6-K/A: Report of foreign private issuer [Rules 13a-16 and 15d-16] (Amendment)

Dec 10 21:35

6-K: Report of foreign private issuer (related to financial reporting)

Dec 5 05:17

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 3 21:01

EFFECT: Others

Nov 27 19:03

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ronald Hafner(8.1%)

Nov 22 05:05

F-3/A: Registration statement for specified transactions by certain foreign private issuers (Amendment)

Nov 19 05:16

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Nov 18 21:33

6-K: Report of foreign private issuer (related to financial reporting)

Nov 16 06:03

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(8.1%),Lind Global Partners II LLC(8.1%), etc.

Nov 15 08:32

SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)

Nov 15 04:36

6-K: Report of foreign private issuer (related to financial reporting)

Nov 13 05:06

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Nov 9 05:06

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Nov 7 05:02

425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 6 05:33